In renal cell cancer gene involved in mutation
## **Core Concept**
Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the small tubes in the kidney that transport waste molecules from the blood to the urine. The most common genetic alterations in RCC involve the **VHL (Von Hippel-Lindau)** gene, which is a tumor suppressor gene. Mutations in this gene can lead to the development of both sporadic and familial forms of renal cell carcinoma.
## **Why the Correct Answer is Right**
The **VHL gene** is crucial in regulating the cellular response to hypoxia. Under normal conditions, the VHL protein helps to ubiquitinate and degrade **HIF (Hypoxia-Inducible Factor)** proteins. In the absence of functional VHL, HIF accumulates, leading to the transcription of genes involved in angiogenesis, glucose metabolism, and cell proliferation, which are factors that contribute to tumor growth. Mutations or deletions in the VHL gene are associated with an increased risk of developing clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer.
## **Why Each Wrong Option is Incorrect**
- **Option A:** While **KRAS** mutations are commonly associated with other types of cancers (e.g., pancreatic, lung, and colorectal cancers), they are not the primary genetic alteration involved in renal cell carcinoma.
- **Option B:** **TP53** is a tumor suppressor gene often mutated in various cancers, but it is not specifically identified as a primary mutation in renal cell carcinoma.
- **Option D:** **BRCA1** and **BRCA2** are genes associated with breast and ovarian cancers, not primarily with renal cell carcinoma.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **Von Hippel-Lindau disease**, a hereditary condition caused by mutations in the **VHL gene**, significantly increases the risk of developing renal cell carcinoma, as well as other tumors like hemangioblastomas of the retina and cerebellum, and pheochromocytomas. Patients with VHL disease require regular screening for these associated tumors.
## **Correct Answer:** .